Venture Valuation

Gamil de Chadarevian, vice chairman of the board of Antigenics Inc, has recently joined the advisory board of Venture Valuation, Switzerland. He will advise and support the company on its expansion of the biotech and life sciences company database 'Biotechgate' in Europe, and Venture Valuations assessment and valuation services. Biotechgate (www.biotechgate.com), is an extended directory of European companies in the biotechnology and life sciences field. Featured countries include: Austria (www.austrianbiotech.com), France (www.frenchbiotech.com), Italy (www.italianbiotech.com) and Switzerland (www.swisslifesciences.com). De Chadarevian was very instrumental in starting the Italian biotech database which was developed in cooperation with the governmental organisation InvestinItaly. As a serial entrepreneur, investor and biotechnology expert, de Chadarevian supports Venture Valuation also in the expansion of its independent, third party valuations. He is on the advisory board of Venture Valuation along with Dr Christian Suter, formerly director of research and development of Hoffmann-LaRoche's vitamin division and Prof Cuno Pümpin, extraordinarius for management at the University of St Gallen, entrepreneur and also on the advisory board of Invision and The Blackstone Group.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH